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Purpose: The purpose of this study was to investigate to what extent the outcomes of a discrete 
choice experiment (DCE) differ based on respondents’ psychological distance to the decision 
at hand.
Methods: A DCE questionnaire regarding individuals’ preferences for genetic screening for 
colorectal cancer (CRC) within the Dutch national CRC screening program was created. The 
DCE contained nine D-efficient designed choice tasks and was distributed among two populations 
that differ in their psychological distance to the decision at hand: 1) a representative sample 
of the Dutch general population aged 55–65 years, and 2) a sample of Dutch individuals who 
attended an information appointment regarding colonoscopies following the detection of blood 
in their stool sample in the CRC screening program. The DCE consisted of four attributes related 
to the decision whether to participate in genetic screening for CRC: 1) risk of being genetically 
predisposed, 2) risk of developing CRC, 3) frequency of follow-up colonoscopies, and 4) survival. 
Direct attribute ranking, dominant decision-making behavior, and relative importance scores 
(based on panel MIXL) were compared between the two populations. Attribute level estimates 
were compared with the Swait and Louviere test.
Results: The proportion of respondents who both ranked survival as the most important attribute, 
and showed dominant decision-making behavior for this attribute, was significantly higher in 
the screened population compared to the general population. The relative importance scores of 
the attributes significantly differed between populations. Finally, the Swait and Louviere test 
also revealed significant differences in attribute level estimates in both the populations.
Conclusion: The study outcomes differed between populations depending on their psychologi-
cal distance to the decision. This study shows the importance of adequate sample selection; 
therefore, it is advocated to increase attention to study sample selection and reporting in DCE 
studies.
Keywords: discrete choice experiment, preferences, stated preferences, sample, psychological 
distance, genetic screening
Introduction
Discrete choice experiments (DCEs) are used to elicit individuals’ preferences for 
goods, products, and services.1–3 In a DCE, respondents are asked to state their prefer-
ences by completing several hypothetical choice tasks. DCEs are built on the random 
utility theory (RUT), assuming that decisions about any good, product, or service 
depend on the valuation of the levels of its characteristics or attributes.1–3 DCEs are 
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increasingly being used in health care and public health4,5 
for different purposes, the provision of accurate insights in 
preferences of the target population for specific treatment 
characteristics is one example. This enables drug developers 
and/or program designers to 1) develop and adjust treatments 
to reflect the preferences of anticipated users and 2) provide 
accurate estimates of the potential uptake rate of a treatment. 
Since this implies that DCEs can be used as input for policy-
making, the accuracy and validity of measured (ie, stated) 
preferences are essential. In other words, for stated prefer-
ences to accurately reflect revealed preferences, they should 
at least be measured among the actual target population for 
the intervention at hand.
Identifying the target population and recruiting the study 
sample are often relatively straightforward tasks when study-
ing preferences for specific and available treatments. Patients, 
especially the chronically ill, often have experience with 
decision-making in relation to treatment or health, which 
adds to the validity of the elicited preferences.3 However, in 
a number of other health care situations, particularly in the 
public health setting, defining target populations and recruit-
ing study samples is less straightforward. For some newly 
designed treatments or preventive initiatives, the exact target 
population might not even exist (yet), for instance in rela-
tion to genetic screening. For this reason, several DCEs on 
public health initiatives, a sample of the general population is 
recruited instead.5–7 In contrast to patients, such populations 
might be less experienced in making health-related decisions. 
They might also have problems imagining situations that are 
unfamiliar and do not apply to them at this particular point in 
life. Eliciting preferences from such relatively inexperienced 
(general) populations for a specific public health initiative, 
which will only become available in the future, might lead 
to biased estimates. In which case respondents’ stated prefer-
ences inaccurately reflect revealed preferences of the actual 
target population.
Several theories suggest that individuals’ attitudes, 
preferences, and intentions are influenced by awareness, risk 
perception, experience, and time to the event in question.8–16 
In particular the construal level theory, postulating 
individuals’ preferences depends on their psychological 
distance to the decision at hand.14,15 Psychological distance 
has several dimensions, among which temporal distance 
(time to the event) and hypothetical distance (experience 
with the event) are most relevant in health-related decision-
making.14,15 For example, if people are asked to express their 
preferences in relation to a future cancer screening test that is 
years away, the psychological distance is vast, which suggests 
that their decisions will reflect rather the abstract thoughts 
about the characteristics of the screening (eg, improved life 
expectancy).17 If asked to express their preferences regarding 
the same screening test being introduced next week, people 
will likely depend on more concrete thoughts about the 
characteristics of screening test instead (eg, the discomfort of 
the test).17 This example illustrates the fact that individuals’ 
decision-making regarding more distant events results in 
high construal and relative abstract thinking, while decision-
making regarding more close and upcoming events results 
in low construal and relative concrete thinking.14,15 The aim 
of this study was to investigate if and to what extent the out-
comes of a DCE differ based on respondents’ psychological 
distance to the decision at hand.
Materials and methods
Dce case study
A DCE on preferences for genetic screening for colorectal 
cancer (CRC) was used as a case for this study. From 2014 
onward, all Dutch residents aged 55–75 years are gradually 
invited to participate in the national population-based 
screening program for CRC, which is based on a fecal 
immunochemical test (FIT). If the test is positive (ie, blood 
is detected in stool, indicating an increased CRC risk), a 
colonoscopy is planned and participants are asked to report 
on their family cancer history. Depending on colonoscopy 
findings and family history results, further genetic analysis 
might be advised.
study populations
For our purpose, we recruited two separate samples of par-
ticipants who differed in relative psychological distance to 
genetic screening for CRC.
Population 1 – general population
Individuals were eligible to participate in this part of the 
study if they were 55–65 years of age and were not yet 
invited to participate in the national CRC screening program. 
Respondents were recruited via an existing online panel of 
the general Dutch population. The sample is representative 
for the entire target population with respect to age, gender, 
and educational level. In total, 5,500 individuals were invited 
to participate in this study and recruitment continued until at 
least 500 questionnaires were completed in full.18
Population 2 – screened population
Individuals were eligible to participate in this part of the study 
if they had participated in the Dutch population-based CRC 
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screening (as introduced in 2014 for all Dutch citizens aged 
55–75 years), had a subsequent positive FIT, and were attend-
ing an intake appointment for a colonoscopy at the Bergman 
Clinics IZA or IZB. Questionnaires were handed out to all 
individuals fulfilling the above criteria. In total, endoscopy 
nurses handed out 675 questionnaires of which 288 were 
returned (43%). Excluding all respondents with .10% 
missing choice tasks resulted in 210 usable questionnaires.
For the total study, the Dutch Central Committee on 
Research involving Human Subjects concluded that formal 
testing by an institutional review board was not necessary, 
as respondents were only required to complete an anony-
mous and noninvasive questionnaire once (the decision to 
complete the survey either online or on paper was deemed to 
be informed consent for this study), which is in accordance 
with the Dutch legislation and guidelines laid down in the 
Declaration of Helsinki.
Attributes, levels, and experimental design
To construct the DCE used for this study, attributes were 
selected based on previously published studies,19–27 inter-
views with six experts (ie, a scientist with a specific interest 
in public health genomics, a scientist with a specific interest 
in ethics of genetics/genomics, a specialist in cancer genetics, 
and three medical specialists in gastroenterology), and five 
group interviews28 (n=38) with individuals from the target 
population. Further details on the selection of the attributes 
and levels for this DCE are described in Veldwijk et al18 
Finally, four attributes with three levels each were selected 
for this DCE (Table 1).
NGene 1.0 (ChoiceMetrics, 2011) software was used 
to develop a D-efficient main-effects design.29 A design 
was constructed based on a panel mixed-multinomial-logit 
model, using effect codes for all attributes and including 
beta priors from the pilot study. The DCE consisted of nine 
unique choice tasks each containing two alternatives. Before 
participants were asked to complete the choice tasks, they 
received detailed information on the meaning of all attributes 
and levels as well as an explanation on how to complete a 
choice task, illustrated by an example. Although the design 
included forced choices, participants were asked after each 
choice task whether they would actually participate in the 
chosen situation or not (ie, opt-out). The draft questionnaire 
was pilot tested among a subgroup (n=90) of the popula-
tion, of which four (n=4) were “think aloud” tests. Whether 
correct wording was used and whether the target population 
understood the attributes, levels, and choice tasks were tested.
Questionnaire
The final questionnaire consisted of the DCE as described 
above, as well as a separate section of background questions 
which respondents answered before completing the DCE. 
This section of the questionnaire comprised questions on 
demographics such as gender, age, educational level, health 
literacy, and ethnicity. Educational level was dichotomized 
into higher (ie, tertiary education) or lower education (ie, all 
other educational levels). Health literacy was measured by a 
validated Dutch version of the Set of Brief Screening Ques-
tions (SBSQ)30 in which participants scored three questions on 
a 5-point Likert scale ranging from 0 to 4. An average score 
Table 1 Attributes and levels that were included in the Dce
Attributes Level 1 Level 2 Level 3
Probability of being genetically predisposed (genetic predisposition): the likelihood that you are 
genetically predisposed to develop colorectal cancer
1%
1 out of 
every 100
3%
3 out of 
every 100
15%
15 out of 
every 100
Probability of developing crc (crc risk): 5 out of every 100 (5%) Dutch individuals develop 
colorectal cancer. if you have a genetic predisposition to develop colorectal cancer and you do not 
participate in preventive colonoscopies, the likelihood that you will develop colorectal cancer is 
higher and varies between
15%
15 out of 
every 100
70%
70 out of 
every 100
99%
99 out of 
every 100
Frequency of preventive colonoscopies (colonoscopy frequency): if the genetic test shows that 
you are genetically predisposed to develop colorectal cancer, you will be invited to participate in 
preventive colonoscopies. These colonoscopies are performed to prevent cancer from developing 
or to diagnose cancer in an early stage. These colonoscopies will be scheduled on a regular basis 
varying between
every year every 2 
years
every 5 
years
Probability of surviving crc (survival): 60 out of every 100 (60%) Dutch individuals with colorectal 
cancer survive over the next 5 years. if you know you are genetically predisposed to develop 
colorectal cancer and if you participate in the preventive colonoscopies, the likelihood that you will 
survive colorectal cancer over the next 5 years will increase and varies between
80%
80 out of 
every 100
92%
92 out of 
every 100
98%
98 out of 
every 100
Abbreviations: crc, colorectal cancer; Dce, discrete choice experiment.
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of #2 indicates inadequate health literacy, while an average 
score of .2 indicates adequate health literacy.30 Ethnicity 
was dichotomized into Dutch vs non-Dutch. The part of the 
questionnaire that included the DCE also included a direct 
ranking exercise during which respondents were asked to 
mark the attribute which they thought was most important 
for their decision regarding genetic testing for CRC.
statistical analyses
Direct attribute ranking
Direct attribute ranking scores were obtained from all respon-
dents in both the populations. Chi-squared tests were used 
to test whether the proportion of respondents who ranked 
a certain attribute as most important differed between the 
general and screened population.
Dominant decision-making behavior
The proportion of respondents who always chose to opt-out, 
who always chose the scenario with the highest survival, 
and who always chose the highest frequency of preventive 
colonoscopies was calculated within both the populations. 
Chi-squared tests were conducted to test whether these 
proportions differed significantly between the general and 
the screened population.
Preference heterogeneity and relative importance
Nlogit 5.0 (econometric software) was used to estimate the 
panel mixed multinomial logit (MIXL) models which were 
chosen for this study to adjust for the multilevel structure of 
the data (every respondent answered nine choice tasks) and 
to be able to allow for preference heterogeneity.31 Results 
were considered statistically significant when P,0.10. 
Only forced choices were analyzed. The systematic utility 
component (V) describes the measurable part of the utility 
of a specific genetic screening test based on the attributes 
that were included in the DCE, which was tested using the 
following equation:
V =  β0
i
 + β1 genetic predisposition
3%
 + β2 genetic pre-
disposition
15%
 + β3
i
 CRC risk
70%
 + β4
i
 CRC risk
99%
 + 
β5
i
 colonoscopy frequency
2years
 + β6
i
 colonoscopy 
frequency
5years
 + β7
i
 survival
92%
 + β8
i
 survival
98%
β
1
–β
8
 are the attribute level estimates that indicate the 
relative importance of each attribute level. The sign of 
the estimate indicates whether the attribute level has a posi-
tive or a negative influence on the utility. β
0
 was included 
as an alternative specific constant term. All attributes were 
considered categorical and therefore recoded using effects 
coding, accounting for potential non-linearity.32 In contrast 
to dummy coding, this coding procedure codes the reference 
category as –1 and the sum of the effect coded attribute levels 
is always zero.32 The coefficient for the reference categories 
of the attributes included in this study are therefore calcu-
lated as –1*(β effect code 1 + β effect code 2). Based on 
the significance of the estimates of the SD, which attributes 
should be included as random parameters due to significant 
preference heterogeneity and with what distribution (CRC 
risk, colonoscopy frequency, and survival were included 
as random parameters, all with normal distributions) were 
determined.
Relative importance scores were calculated based on the 
results of the panel MIXL models separately for the general 
and the screened population. Within each attribute, the dif-
ference between the estimates of the smallest and largest 
attribute level estimate was calculated. The largest differ-
ence value received an importance score of 1, and the other 
difference values were divided by the largest difference value, 
resulting in a relative distance of all attributes compared to 
the most important attribute.
Differences in attribute level estimates and the role 
of the scale parameter
When comparing the attribute level estimates of two data 
sets, the role of the scale parameter should be taken into 
account. The attribute level estimates that are estimated in 
the multinomial logit (MNL) model are a ratio of the true 
parameter estimates and a scale parameter (ie, inverse vari-
ance). Since variances differ between data sets, the attribute 
level estimates cannot be compared directly between data 
sets before scale factor differences (variance differences) 
between the models are ruled out.33 The Swait and Louviere 
test was used for this purpose.33 For further details on the 
procedure, see Supplementary material S1.
sensitivity analyses
About 25% of the respondents from the screened popula-
tion was excluded due to .10% missing choice tasks (ie, 
missing answers on two or more choice tasks). In most 
instances these were consecutive choice tasks; therefore, it 
is assumed that this was most likely due to accidently skip-
ping a page (implying 2–4 missed choice tasks at once). 
To ensure robustness of our results, all DCE analyses were 
conducted separately for data sets including and excluding 
these respondents. In addition, since older age and male 
gender are associated with a higher likelihood of CRC and 
thereby positive FIT,25 significant differences in demographic 
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characteristics were expected and were also found between 
the general and screened population. To account for these 
obvious and significant differences, separate analyses were 
conducted to investigate the role of the scale parameter by 
means of matching respondents of both the populations 
through propensity scores,34 as well as comparing data sets 
separately for males, females, lower educated respondents, 
higher educated respondents, and respondents aged 
55–65 years only.
Results
respondents’ characteristics
Respondents in the general population were significantly 
younger (59.5 vs 65.5 years of age) compared to respondents 
in the screened population (Table 2). The general population 
sample consisted of significantly more females (50.9% vs 
39.2%), respondents with inadequate health literacy (3.4% vs 
1.0%) and respondents with a Dutch origin (96.6% vs 93.3%) 
compared to the screened population (Table 2).
Direct attribute ranking
In the screened population, a significantly higher proportion 
of respondents indicated that survival was the most impor-
tant attribute for them compared to the general population 
(64% vs 56%, P=0.05). Regarding the importance of the other 
attributes, no significant differences were found between the 
populations.
Dominant decision-making behavior
The proportion of respondents in the screened population 
who always chose the alternative with the highest survival 
was significantly higher compared to the proportion in the 
general population (13.8% vs 9.2%, P=0.07). Although the 
proportion of respondents who always chose to opt-out and 
always chose the alternative with the highest frequency of 
preventive colonoscopies was higher in the general popula-
tion compared to the proportion in the screened population, 
this difference was not statistically significant (opt-out: 
3.6% vs 2.4%, P=0.41; frequency of colonoscopies: 11.1% vs 
8.6%, P=0.31).
Preference heterogeneity and relative 
importance
Within both the MNL and panel MIXL, the attribute level 
estimates show equal directions in the general and the 
screened population (Table 3). For instance, all respondents 
preferred a survival of 98% over a survival of 80% and 
biannual preventive colonoscopies over having a preventive 
colonoscopy every 5 years. Significant preference hetero-
geneity was shown for three out of the four attributes in 
both samples (Table 3). The relative importance scores of 
the attributes differed between the general and the screened 
population. Although survival was most important in both 
populations the distance of the importance values of the other 
attributes relative to survival were smaller in the general 
population compared to the screened population (Table 3).
Differences in attribute level estimates 
and the role of the scale parameter
Identifying the scale parameter according to the Swait and 
Louviere test can only be performed by using an MNL model. 
The log likelihood of the MNL model was fitted separately 
in both the data sets (general population: -2,897.5; screened 
population: -1,041.4) and those were tested against the 
log likelihood of the MNL model for the pooled data set 
(-4,310.5), which accounted for potential scale parameter 
differences (scale parameter was estimated at 1.22; Figure 1). 
By means of the chi-squared test the hypothesis of equal 
attribute level estimates was rejected (P,0.05). The differ-
ences in attribute level estimates between the general and the 
screened population were statistically significant.
sensitivity analyses
Including the respondents with .10% missing values on 
their choice tasks did not change any of the study outcomes. 
In addition, the significant differences in attribute level 
estimates between the general and the screened popula-
tion were also confirmed when accounting for differences 
in demographic variables by means of propensity scores. 
Table 2 Demographic characteristics of both the study populations
 
 
General population
(n=532)
Screened population
(n=210)
Mean (SD) % Mean (SD) %
Agea 59.5 (3.1)  65.5 (4.4)  
gendera
Female  50.9  39.2
educational level
low  63.2  58.1
high  36.8  41.9
health literacya
inadequate  3.4  1.0
ethnicity
Dutch  96.6  93.3
Note: aSignificant (P,0.10) difference between the general population and screened 
population.
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Table 3 Preferences for genetic testing for colorectal cancer based on MNL and panel MIXL stratified by study population
Attributes Level MNL Panel MIXL
General 
population
Screened 
population
General population Screened population
Estimate SE Estimate SE Estimate SE RIS Estimate SE RIS
Mean value
constant  0.14*** 0.03 0.19*** 0.05 0.25*** 0.05  0.34*** 0.08  
genetic 
predisposition
1% (ref) -0.06* 0.03 -0.10* 0.05 -0.11*** 0.04 0.45 -0.15** 0.06 0.32
3% -0.18*** 0.03 -0.12** 0.05 -0.34*** 0.04 -0.26*** 0.07
15% 0.24*** 0.03 0.22*** 0.05 0.45*** 0.04 0.41*** 0.07
crc risk 15% (ref) -0.07** 0.03 -0.14** 0.05 -0.13*** 0.05 0.18 -0.23** 0.08 0.19
70% 0.08*** 0.03 0.07 0.05 0.19*** 0.04 0.17** 0.07
99% -0.01 0.03 0.07 0.05 -0.06 0.05 0.06 0.08
colonoscopy 
frequency
every year (ref) 0.21*** 0.03 0.15** 0.06 0.38*** 0.08 0.76 0.18 0.12 0.56
every 2 years 0.29*** 0.03 0.31*** 0.05 0.48*** 0.04 0.49*** 0.07
every 5 years -0.50*** 0.04 -0.46*** 0.06 -0.86*** 0.09 -0.67*** 0.13
survival 80% (ref) -0.52*** 0.03 -0.60*** 0.05 -0.90*** 0.07 1.00 -1.08*** 0.12 1.00
92% 0.01 0.03 0.02 0.04 0.04 0.03 0.07 0.06
98% 0.51*** 0.04 0.58*** 0.06 0.86*** 0.07 1.01*** 0.12
SD
constant      0.55*** 0.08  0.44*** 0.14  
crc risk 15% (ref)     0.58 0.65  0.62 0.59  
70%     0.11 0.14  0.26** 0.12  
99%     0.57*** 0.06  0.56*** 0.09  
colonoscopy 
frequency
every year (ref)     1.42*** 0.26  1.34*** 0.28  
every 2 years     0.23** 0.09  0.23* 0.13  
every 5 years     1.40*** 0.09  1.32*** 0.12  
survival 80% (ref)     0.59 1.50  0.77 2.92  
92%     0.03 0.05  0.03 0.08  
98%     0.59*** 0.07  0.77*** 0.11  
Notes: The attribute level estimate of the reference categories can be calculated as -1*(sum of the other attribute level estimates); *P,0.10; **P,0.05; ***P,0.001.
Abbreviations: crc, colorectal cancer; MiXl, mixed multinomial logit; ris, relative importance score; Mnl, multinomial logit; se, standard error.
Finally, when performing the above-mentioned scale param-
eter analysis separately for males, females, lower educated 
respondents, higher educated respondents, and respondents 
aged 55–65 years, significant differences in the attribute level 
estimates between the general and the screened population 
were confirmed.
Discussion
This study shows that selecting different target populations 
for the same DCE yields different study outcomes. Respon-
dents with different psychological distance to the decision at 
hand showed differences in terms of direct attribute ranking, 
dominant decision-making behavior, relative importance 
scores, and attribute level estimates. Respondents with higher 
risk of being diagnosed with CRC (screened population) are 
(by definition) closer to the actual decision-making in rela-
tion to genetic testing.
Results of this study are in line with the assumptions of 
the construal level theory, where more distant decisions are 
processed on a higher level using more abstract notions of the 
event, while decisions that are closer in time are processed 
on a lower level using more concrete features of the deci-
sion.14,15 Respondents in the screened population focused 
on the more concrete aspects of the decision, namely the 
survival attribute, and less on the more abstract attributes, 
ie, “genetic predisposition” and “CRC risk.” Although “colo-
noscopy frequency” initially seems to be one of the more a 
concrete attributes, results show that it was not as important 
for decision-making in the screened population as it appear 
to be in the general population. There are two separate 
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Figure 1 Log likelihood values for all fitted MNL models containing a different trial 
version of the expected scale factor.
possible explanations for this: first, respondents in the 
screened population had already experienced a consultation 
where they had received information about colonoscopies. 
This might have lowered their level of anxiety in relation 
to the procedure, and adjusted their (possibly unrealistic) 
expectations about the preventive capability this procedure 
has (ie, the misconception that more frequent colonoscopies 
reduces the risk of developing CRC).18,35,36 Second, if the pos-
sibility of one’s own death becomes probable and realistic, 
people tend to focus on this fact, disregarding other factors 
(ie, death priming).16,37–39 It is possible that the results from 
this DCE have been influenced by this as the results reveal a 
significantly larger proportion of respondents in the screened 
population showing dominant decision-making behavior in 
relation to the survival attribute in the DCE.
In this context, it is important to mention that being based 
on the RUT,1–3 DCEs are subject to rather strong assump-
tions regarding rational decision-making. In this paper, we 
show that these strong assumptions do not necessarily hold. 
Responses from respondents with a large psychological 
distance (ie, general population) were more in line with the 
underlying theory, however, their stated preferences are not 
in alignment with responses from the actual target population 
(ie, screened population). Therefore, we issue a word of cau-
tion against conducting DCES in the general population to 
predict preferences and uptake regarding specific treatments 
within an actual target/patient population. Based on the cur-
rent study results, we recommend to pay more attention to 
the context in which respondents make decisions (acknowl-
edging psychological distance as a feature) in future DCEs. 
When designing their DCEs, researchers need to consider the 
contextual factors that might affect preferences and (when 
possible) control for them. Of course, selecting the adequate 
population is vital. However, if the target population does not 
exist (yet) or the topic of the DCE is completely unfamiliar to 
the population, other measures to either reduce or control for 
the effect of psychological distance on preferences need to be 
evaluated.40 For example, the use of refined educational tools 
such as serious games (scenario-based educational tools)41–43 
could help to improve respondents’ ability to imagine the 
choice situations. Such tools may also be a means to control 
the way in which concrete features at large distance influence 
people.40 Selecting the right population, or eliciting well-
informed preferences from a more distant population that has 
been educated on the topic, has the potential to significantly 
improve the external validity of DCEs.
In addition, we identify a need for more research to 
determine whether the effects of psychological distance 
on preferences is constant over different decision situa-
tions, disease areas and respondent populations. If this is 
the case, researchers using DCE to study preferences in 
relation to new treatments or preventive initiatives where 
the actual target population is not (yet) fully defined, will, 
at least, be clear about the potential bias of their results 
incurred by the respondents psychological distance to the 
decision at hand.
This study was subject to some limitations. First, given 
the context of this study (CRC screening), the current sample 
was relatively older compared to the general Dutch popula-
tion. Since higher age is potentially associated with greater 
experience with making health-related decisions, differ-
ences in preferences due to psychological distance might 
be even greater among the younger population. Second, in 
agreement with other questionnaires and previous DCEs, 
the current sample included a lower number of individuals 
from an ethnic minority than present in the general popula-
tion. Cultural differences in such subpopulations may impact 
psychological distance, but those effects are unknown from 
this study. Third, although this study included respondents 
from two populations that differed in their psychological 
distance toward the decision, the actual target population of 
genetic tests for CRC (ie, individuals with confirmed CRC 
after colonoscopy and/or a specific family history) could 
not be included. Since differences in outcomes were already 
identified using the current samples, it is expected that those 
differences would even be more pronounced when compar-
ing the general population to this actual target population. 
Finally, the current study used a minimal design, since only 
nine choice tasks were included. As a general rule of thumb, 
we would have power to estimate eight (9 – 1) parameters in 
such a design. However, because of the similarity between 
the results of the MNL model and the panel MIXL presented 
in our paper, the fact that we only estimated generic attribute 
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level estimates, we have no indications that the presented 
results would not be sound.
Conclusion
In this study, direct attribute ranking, dominant decision-
making behavior, relative importance scores, and attribute 
level estimates differed when comparing two populations 
with a different psychological distance to the decision at 
hand. This study shows the importance of adequate sample 
selection. It is therefore advocated to increase attention to 
study sample selection and reporting in DCE studies.
Acknowledgments
Authors would like to thank Josepine Fernow of the Centre 
for Research Ethics & Bioethics from Uppsala University 
for her assistance with writing this manuscript. This paper 
was presented at the International Choice Modelling Confer-
ence and at the International Academy of Choice Modelling 
Conference as an oral presentation with interim findings. The 
abstract was published on the International Choice Model-
ling Conference website (http://www.icmconference.org.uk/
index.php/icmc/ICMC2017/paper/view/1071) and printed 
within an abstract book (attendee access only) for both the 
conferences.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Hensher D, Rose JM, Greene WH. Applied choice analysis: second 
edition. Cambridge, UK: Cambridge University Press; 2015.
 2. Louviere JJ, Hensher DA, Swait JD. Swait, stated choice methods; 
analysis and application. Cambridge: Cambridge University Press; 2000.
 3. Amaya-Amaya M, Gerard K, editor. Using Discrete Choice Experiments 
to Value Health and Health Care. Dordrecht: Springer; 2008.
 4. Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. 
Discrete choice experiments in health economics: a review of the 
literature. Pharmacoeconomics. 2014;32(9):883–902.
 5. de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments 
in health economics: a review of the literature. Health Econ. 2012; 
21(2):145–172.
 6. Marshall D, Bridges JF, Hauber B, et al. Conjoint analysis applications 
in health – how are studies being designed and reported? An update 
on current practice in the published literature between 2005 and 2008. 
Patient. 2010;3(4):249–256.
 7. Watson V, Becker F, de Bekker-Grob E. Discrete choice experiment 
response rates: a meta-analysis. Health Econ. 2017;26(6):810–817.
 8. Glanz K, Rimer BK, Viswanath K, Behavior H. Education: theory, 
research and practice. 4th ed. San Fransisco: Jossey-Bass; 2008.
 9. Ajzen I, Fishbein M. Understanding attitudes and predicting social 
behavior. Englewood Cliffs, NJ: Pretence Hall; 1980.
 10. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis 
Process. 1991;50(2):179–211.
 11. Fishbein M, Ajzen I. Belief, attitude, intention and behavior: an introduc-
tion to theory and research. Reading, MassA: Addison-Wesley; 1975.
 12. Becker MH. The health belief model and personal health behavior. 
Health Education Monographs. Winter, 1974; volume 11, issue 1.
 13. Janz NK, Becker MH. The health belief model: a decade later. Health 
Educ Q. 1984;11(1):1–47.
 14. Liberman N, Trope Y. The role of feasibility and desirability consider-
ations in near and distant future decisions: a test of temporal construal 
theory. J Pers Soc Psychol. 1998;75(1):5–18.
 15. Trope Y, Liberman N. Temporal construal. Psychol Rev. 2003;110(3): 
403–421.
 16. Kahneman D, Tversky A. Prospect theory: an analysis of decision under 
risk. Econometrica. 1979;47(2):263–291.
 17. Mühlbacher AC, Juhnke C. Patient preferences versus physicians’ 
judgement: does it make a difference in healthcare decision making? 
Appl Health Econ Health Policy. 2013;11(3):163–180.
 18. Veldwijk J, Lambooij MS, Kallenberg FG, et al. Preferences for genetic 
testing for colorectal cancer within a population-based screening 
program: a discrete choice experiment. Eur J Hum Genet. 2016;24(3): 
361–366.
 19. Hall J, Fiebig DG, King MT, Hossain I, Louviere JJ. What influences 
participation in genetic carrier testing? Results from a discrete choice 
experiment. J Health Econ. 2006;25(3):520–537.
 20. Kuppermann M, Wang G, Wong S, et al. Preferences for outcomes 
associated with decisions to undergo or forgo genetic testing for Lynch 
syndrome. Cancer. 2013;119(1):215–225.
 21. Matro JM, Ruth KJ, Wong YN, et al. Cost sharing and hereditary cancer 
risk: predictors of willingness-to-pay for genetic testing. J Genet Couns. 
2014;23(6):1002–1011.
 22. Severin F, Schmidtke J, Mühlbacher A, Rogowski WH. Eliciting pref-
erences for priority setting in genetic testing: a pilot study comparing 
best-worst scaling and discrete-choice experiments. Eur J Hum Genet. 
2013;21(11):1202–1208.
 23. Walsh J, Arora M, Hosenfeld C, Ladabaum U, Kuppermann M, 
Knight SJ. Preferences for genetic testing to identify hereditary colorec-
tal cancer: perspectives of high-risk patients, community members, and 
clinicians. J Canc Educ. 2012;27(1):112–119.
 24. American Gastroenterological Association. American gastroenterologi-
cal association medical position statement: hereditary colorectal cancer 
and genetic testing. Gastroenterology. 2001;121(1):195–197.
 25. Dutch Society For Clinical Genetics. CBO guideline hereditary colorec-
tal cancer 2008. Oisterwijk: Van den Boogaard; 2008.
 26. Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evalu-
ation and management of Lynch syndrome: a consensus statement by the 
US Multi-society task force on colorectal cancer. Am J Gastroenterol. 
2014;109(8):1159–1179.
 27. Vasen HFA, van der Meulen-de Jong AE, de Vos Tot Nederveen 
Cappel WH, Oliveira J; ESMO Guidelines Working Group. Familial 
colorectal cancer risk: ESMO clinical recommendations. Ann Oncol. 
2009;20(Supplement 4):iv51–iv53.
 28. Hiligsmann M, van Durme C, Geusens P, et al. Nominal group tech-
nique to select attributes for discrete choice experiments: an example 
for drug treatment choice in osteoporosis. Patient Prefer Adherence. 
2013;7:133–139.
 29. Hensher DA, Rose JM, Greene WH. Applied choice analysis: a primer. 
New York: Cambridge University Press; 2005.
 30. Fransen MP, van Schaik TM, Twickler TB, Essink-Bot ML. Appli-
cability of internationally available health literacy measures in the 
Netherlands. J Health Commun. 2011;16(sup 3):134–149.
 31. Fiebig DG, Keane MP, Louviere J, Wasi N. The generalized multino-
mial logit model: Accounting for scale and coefficient heterogeneity. 
Mark Sci. 2010;29(3):393–421.
 32. Bech M, Gyrd-Hansen D. Effects coding in discrete choice experiments. 
Health Econ. 2005;14(10):1079–1083.
 33. Swait J, Louviere J. The role of the scale parameter in the estima-
tion and comparison of multinomial logit models. J Mark Res. 1993; 
30(3):305–314.
 34. Rosenbaum PR, Rubin DB. The central role of the propensity score in 
observational studies for causal effects. Biometrika. 1983;70(1):41–55.
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
5.
5.
87
.2
46
 o
n 
07
-M
ar
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence 2019:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
281
Veldwijk et al
 35. Grilo Bensusan I, Herrera Martín P, Aguado Álvarez MV. Prospective 
study of anxiety in patients undergoing an outpatient colonoscopy. 
Rev Esp Enferm Dig. 2016;108(12):765–769.
 36. Mikocka-Walus AA, Moulds LG, Rollbusch N, Andrews JM. “It’s 
a tube up your bottom; it makes people nervous”: the experience of 
anxiety in initial colonoscopy patients. Gastroenterol Nurs. 2012;35(6): 
392–401.
 37. Liu W, Aaker J. Do you look to the future or focus on today? The impact 
of life experience on intertemporal decisions. Organ Behav Hum Decis 
Process. 2007;102(2):212–225.
 38. Slovic P, Risk perception of perception of risk. Science. 1987;236(4799): 
280–285.
 39. Wade-Benzoni KA, Tost LP, Hernandez M, Larrick RP. It’s only 
a matter of time: death, legacies, and intergenerational decisions. 
Psychol Sci. 2012;23(7):704–709.
 40. Hamilton RW, Thompson DV. Is there a substitute for direct experience? 
Comparing consumers’ preferences after direct and indirect product 
experiences. J Consum Res. 2007;34(4):546–555.
 41. Syrowatka A, Krömker D, Meguerditchian AN, Tamblyn R. Features 
of computer-based decision aids: systematic review, thematic synthesis, 
and meta-analyses. J Med Internet Res. 2016;18(1):e20.
 42. Reichlin L, Mani N, McArthur K, Harris AM, Rajan N, Dacso CC. 
Assessing the acceptability and usability of an interactive serious game 
in aiding treatment decisions for patients with localized prostate cancer. 
J Med Internet Res. 2011;13(1):e4.
 43. Lieberman DA. Management of chronic pediatric diseases with interac-
tive health games: theory and research findings. J Ambul Care Manage. 
2001;24(1):26–38.
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
5.
5.
87
.2
46
 o
n 
07
-M
ar
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/patient-preference-and-adherence-journal
Patient Preference and Adherence is an international, peer-reviewed, 
open access journal that focuses on the growing importance of patient 
 preference and adherence throughout the therapeutic continuum. Patient 
satisfaction, acceptability, quality of life, compliance, persistence and their 
role in  developing new therapeutic modalities and compounds to optimize 
clinical  outcomes for existing disease states are major areas of interest for 
the  journal. This journal has been accepted for indexing on PubMed Central. 
The  manuscript management system is completely online and includes a very 
quick and fair peer-review system, which is all easy to use. Visit http://www.
dovepress.com/testimonials.php to read real quotes from published authors.
Patient Preference and Adherence 2019:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
282
Veldwijk et al
Supplementary material
The role of the scale parameter
According to the method proposed by Swait and Louviere,1 
the role of the scale parameter when comparing two data sets 
can be determined by confirming that β
1 
= β
2
 and µ
1
 = µ
2
, 
where β represents the attribute level estimates and µ rep-
resents the accompanying standard error. In order to do so, 
a four-step specific procedure that contains two hypotheses 
needs to be followed.
1. An MNL model is fitted within both the population data 
sets separately. For both those models, the log likelihood 
is collected (L
1
 and L
2
).1
2. The attribute level codes in one of the data sets are mul-
tiplied by a trial version of the expected scale factor. The 
two data sets are then combined and the log likelihood 
for this pooled data set is determined (Lµ).
1 This routine 
is repeated for different trial versions of the expected 
scale factor. This second step will result in a list of log 
likelihoods of which 1 represents the model with the 
best fit.
3. The following hypothesis is tested: l
A
 = -2*[Lµ - (L1 + 
L
2
)] , χ2 with (K+1) degrees of freedom.1 In this 
hypothesis, the log likelihood of the optimal model in 
step 2 (while accounting for a specific scale parameter) 
is compared with the log likelihoods of the two separate 
models from step 1. This value is compared with the 
χ2 value of the number of parameters in the model plus 1.1 
If this hypothesis is rejected, the differences in attribute 
level estimates between both the models are statistically 
significant. If this hypothesis is accepted, the attribute 
level estimates of both the models do not differ signifi-
cantly and testing for the scale factor can be continued.
4. Both the data sets from step 1 are pooled and an MNL 
model is fitted. The log likelihood of this model (L
p
) is 
then compared with the log likelihood of the optimal 
model found in step 2 (Lµ), using the following hypothe-
sis: l
B 
= -2[L
p
 - Lµ] , χ
2 with (K+1) degrees of freedom.1 
If this hypothesis is rejected, the scale parameter is statis-
tically different from 1 and differences between the two 
models of both the data sets are explained by scale. If this 
hypothesis is accepted, the models of both the data sets 
are equal and the scale parameter does not differ from 1.
Reference
1. Swait J, Louviere J. The role of the scale parameter in the estimation 
and comparison of multinomial logit models. J Mark Res. 1993;30(3): 
305–314.
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